Canada Clinical Diagnostics Market Analysis

Canada Clinical Diagnostics Market Analysis

$ 3999$ 2999

Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30. The main growth drivers of the Canadian clinical diagnostics market are growing awareness about early disease detection and the benefits of early treatment. Further, the increasing investments by the government in diagnostic services are responsible for the market growth. The market is segmented by molecular diagnostics and end users. LifeLabs, SickKids, and Dynacare are some of the top players in this market.

ID: IN10CAHS003 CATEGORY: Healthcare Services GEOGRAPHY: Canada AUTHOR: Parul Choudhary

Buy Now

Canada Clinical Diagnostics Market Executive Analysis

Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30. Canada covers over 95% of the territory of the second-largest country in the world and about 18% of Canadians reside in rural or remote communities. According to CIHI, overall health spending in Canada will amount to about $8,653 per person in 2022, down from a high of 13.8% in 2020. This represents 12.2% of the country's gross domestic product (GDP). According to new estimates, Canada's health spending will reach $331 Bn in 2022.

Types of Clinical Diagnostics Tests

Laboratory Test: The most commonly ordered tests in Canada include community tests- Complete Blood Count (CBC), creatinine, Thyroid Stimulating Hormone (TSH), etc, inpatient tests- CBC, electrolyte panel, creatinine, etc, and emergency tests- CBC, chem panel 7, liver panel, etc.

Imaging Test: Imaging tests in Canada include X-rays, CT (Computed Tomography) scans, MRI (Magnetic Resonance Imaging) scans Ultrasound, PET (Positron Emission Tomography) scans, Nuclear imaging & mammograms.

Molecular Diagnostics: Molecular diagnostic tests are laboratory tests that employ molecular biology techniques to detect particular genetic material (DNA or RNA) or protein or other molecule linked with a condition or disorder from the sample of tissue, blood, or other body fluids. Molecular diagnostics methods include Polymerase chain reaction (PCR), real-time RT-PCR, and Next-generation sequencing (NGS).

Point-of-care (POC) molecular diagnostics refers to portable tools, tests, and kits that are used to identify and classify diseases in human samples such as feces, blood, serum, and throat swabs. POC testing is quickly gaining acceptance because of its ease of use, comfort, quick turnaround time, and potential to enhance patient outcomes.

Major players providing molecular diagnostics in Canada- LifeLabs, Dynacare, Genecept Assay.

Point of Care Testing

Point-of-care testing (POCT) describes diagnostic procedures carried out by a medical professional or other qualified personnel at or close to the patient's location. This can include tests carried out by patients independently in a community or at home (patient self-testing). Compared to conventional testing, it might be more advantageous because it allows for greater staff and patient mobility, portability between urban and rural settings, and quick turnaround for test results. These elements might hasten clinical judgment and patient management while boosting effectiveness. Canadian states and territories are looking for ways to implement POCT in the delivery of healthcare in a way that is appropriate and efficient in view of this expansion. There are still loopholes in some topics, including the cost-effectiveness, quality, and reliability of POCT as well as the effects of POCT adoption on the healthcare system. Key POCT area includes blood glucose monitoring for diabetes, pregnancy testing, HIV-I, HIV-2 antibody test, etc.

Key Companies in POCT- Abbott Laboratories, BD (Becton, Dickinson, and Company), Roche Diagnostics, Siemens Healthcare, EKF Diagnostics Holdings, etc.

Canada clinical diagnostics market report 2022 to 2030

Market Dynamics

Market Growth Drivers

Increasing awareness about the importance of early disease detection and the benefits of early treatment is driving the growth of the Canada clinical diagnostics market. The federal government proposed Bill C-17 in the House of Commons, which would give provinces and territories an extra $2 Bn as a one-time top-up, split equally per population are some of the government initiatives which are responsible for the Canada clinical diagnostics market expansion.

Market Restraints

Patients have to wait an unreasonable amount of time for life-saving treatments due to a lack of medical imaging equipment and proper health human resources for the reporting of the images. This significantly limits the growth of Canada's clinical diagnostics market. Growing concerns about data privacy and security are also a restraint to the growth of the Canada clinical diagnostics market, as the storage and use of sensitive patient information is a major concern.

Competitive Landscape

Key Players

  • LifeLabs- LifeLabs has been addressing Canadians' healthcare needs for over 50 years since its foundation year as BC Biomedical. They aid in the diagnosis, treatment, monitoring, and prevention of disease
  • SickKids- January 2023, SickKids ranked as one of Canada's Top 40 Research Hospitals, as first for hospital intensity and also for researcher intensity for the year 2022
  • Dynacare- Dynacare provides a comprehensive variety of laboratory testing services, including regular and specialized tests in hematology, clinical chemistry, immunology, and genetics to over 165 patient care centers across Quebec, Ontario, Manitoba, Alberta, and British Columbia in Canada
  • MIC Medical Imaging- MIC has been an important provider of health care services in Northern Alberta, running 13 community-based imaging clinics and supplying contract services to 12 Edmonton area hospitals and community health centers
  • Public Health Ontario- PHO assumed a leading role in the Ontario COVID-19 Genomics Network and the COVID-19 Testing Strategy Expert Panel, in addition to participation in the COVID-19 Provincial Diagnostic Network in Ontario
  • Biron- Biron is a provider of laboratory testing and diagnostic imaging services in Canada. Biron operates 120 patient service centers sleep clinics and laboratory facilities across Canada
  • Akumin- The firm offers a chain of diagnostic imaging facilities that provide a variety of services such as MRI, CT, PET/CT, X-Ray, Ultrasound, and other diagnostic services
  • EFW Radiology- EFW Radiology offers extensive diagnostic and interventional imaging services in Calgary. They provide a wide range of imaging services, including X-rays, ultrasound, mammography, magnetic resonance imaging (MRI), computed tomography (CT), nuclear medicine, and interventional radiology

Notable Deals

  1. In December 2022, LifeLabs announced a new partnership with Natera, Inc., a global pioneer in cell-free DNA testing, to provide individualized cancer testing in Canada via Natera's SignateraTM Residual Disease Test & in the same year, also introduced a new patient service center in Kanata, Ottawa
  2. In June 2022, InsideTracker, the leading, completely individualized performance and nutrition solution, announced a partnership with Dynacare
  3. In September 2021, PocketHealth, the creator of healthcare's most innovative digital image-sharing solution, announced how MIC Medical Imaging opted for its platform to make diagnostic image-sharing more accessible for patients
  4. In June 2021, Akumin Inc., made a strategic partnership with Philips to install the new Radiology Operations Command Centre across Akumin's urgent care imaging centers and co-create clinical standards for Akumin's MR and CT imaging technologies

Healthcare Policies and Regulatory Landscape

Health Canada's Health Products and Food Branch (HPFB) is the national authority that regulates, evaluates, and monitors the safety, efficacy, and quality of therapeutic and diagnostic products available to Canadians. Assisted Human Reproduction Act and its regulations, as well as the Food and Drug Act, make up the HPFB's legislative foundation. Additionally, it aids in achieving international participation in certain fields like cutting-edge technologies and medical devices.

The Medical Device Bureau of the Therapeutic Products Directorate (TPD) is the national authority responsible for regulating the quality, effectiveness, and safety of medical devices in Canada. Registration of medical devices in Canada can be done through two pathways- Medical Device Establishment License (MDEL) and Medical Device License (MDL).

Standards Council Of Canada (SCC) is a crown organization created in 1970 as a result of an Act passed by Parliament with the goal of encouraging and advancing voluntary standardization in Canada. SCC offers an internationally recognized accreditation program for medical testing laboratories across Canada.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Canada Clinical Diagnostics Market Segmentation

By Molecular Diagnostics

  • Polymerase Chain Reaction
  • Next-Generation Sequencing
  • Isothermal Nucleic Acid Amplification Technology
  • Microarray
  • In-situ Hybridization
  • Immunohistochemistry
  • Other Technologies

By End User

  • Hospital Laboratory
  • Diagnostic Laboratory
  • Point-of-care Testing

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 20 May 2024
Updated by: Shivam Zalke

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter